Obstetrics

Multiple Pregnancy

Twin and triplet pregnancy is higher risk than singleton pregnancy; early determination of chorionicity and amnionicity drives surveillance, fetal-medicine referral, preterm-birth prevention and timing and mode of birth.

In a nutshell

Multiple pregnancy is managed by chorionicity and amnionicity. Determine these early, label the fetuses, provide specialist surveillance and refer monochorionic complications promptly. NICE recommends cervical-length screening at 16–20 weeks, vaginal progesterone when the cervix is 25 mm or less, and planned birth at 37 weeks for uncomplicated DCDA twins, 36 weeks for MCDA twins, 32+0–33+6 weeks for MCMA twins and 35 weeks for uncomplicated trichorionic or dichorionic triamniotic triplets.

Classic presentation

A first-trimester scan shows monochorionic diamniotic twins. Document the T-sign and fetal labels, arrange fortnightly surveillance from 16 weeks, screen cervical length at 16–20 weeks, assess pre-eclampsia risk and plan birth at 36 weeks if uncomplicated.

Key points

  • Chorionicity and amnionicity, not zygosity, determine risk and surveillance.
  • Monochorionic complications include TTTS, selective growth restriction and TAPS.
  • Offer cervical-length screening at 16–20 weeks and vaginal progesterone for a cervix 25 mm or less.
  • Offer aspirin only when NICE pre-eclampsia risk criteria are met; multifetal pregnancy is one moderate risk factor.
  • Planned birth: DCDA twins 37 weeks, MCDA twins 36 weeks, MCMA twins 32+0–33+6 weeks and uncomplicated triamniotic triplets 35 weeks.

First-line investigation

First-trimester ultrasound to determine gestational age, chorionicity, amnionicity and consistent fetal labels, followed by chorionicity-specific scans.

Management

Classify and label

  • Determine gestational age, chorionicity and amnionicity at the first scan, label each fetus consistently and manage uncertain classification as monochorionic until clarified.1

Start specialist surveillance

  • Use the NICE schedule for the pregnancy type, watch for discordant fluid, growth and Doppler findings, and refer monochorionic complications to tertiary fetal medicine.1

Prevent maternal and preterm complications

  • Offer cervical-length screening and vaginal progesterone when indicated; assess aspirin eligibility and monitor blood pressure, urine protein and anaemia.1,2,3

Plan birth and haemorrhage precautions

  • Offer chorionicity-specific planned birth, individualise complicated pregnancies, agree mode from presentation and complications, and ensure CTG, intravenous access, blood availability and active third-stage management.1,4

Exam traps

  • Monozygotic twins can be dichorionic; zygosity is not the management classification.
  • TTTS requires shared placental circulation.
  • If chorionicity remains uncertain, manage as monochorionic until proven otherwise.
  • Do not give routine untargeted corticosteroids solely because the pregnancy is multiple.
  • Uncomplicated twins with a cephalic first twin after 32 weeks can choose planned vaginal birth or caesarean; monoamniotic twins and triplets differ.

Illustrations

Lambda versus T-signFirst-trimester ultrasound comparing the lambda sign of dichorionic twins with the T-sign of monochorionic diamniotic twins, with a note that amnionicity must also be established.Khalil A et al., Ultrasound in obstetrics & gynecology 2025, CC-BY-4.0 · CC-BY-4.0

Key sources

  1. NICE NG137, Twin and triplet pregnancy (Current NICE guideline published 4 September 2019 and last updated 9 April 2024: chorionicity, surveillance, fetal complications, preterm-birth prevention, timing and mode of birth and intrapartum care)Updated 9 Apr 2024
  2. NICE NG133, Hypertension in pregnancy: diagnosis and management (Current NICE guidance last updated 17 April 2023: aspirin 75–150 mg from 12 weeks for one high-risk or more than one moderate-risk factor, including multifetal pregnancy as a moderate risk factor)Updated 17 Apr 2023
  3. BNF, current prescribing information for pregnancy (UK prescribing source for vaginal progesterone and aspirin in pregnancy; direct access was restricted and local maternity protocols remain necessary)
  4. NICE NG25, Preterm labour and birth (Current NICE recommendations last updated 10 June 2022 for antenatal corticosteroid and magnesium-sulfate decisions when preterm birth is anticipated)Updated 10 Jun 2022

This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.